News
How Nanosized Particles May Affect Skin Care Products
The rapidly growing field of nanotechnology and its future use in cosmetic products holds both enormous potential and potential concern for consumers. Currently, major cosmetic manufacturers have imposed a voluntary ban on the use of nanoparticles in products while they await a ruling from the Food and Drug Administration (FDA) regarding the safety of this technology. However, these manufacturers know that when ingredients in products such as sunscreens and anti-aging products are converted into nanosized particles, the end product displays unique properties that can benefit the skin in ways that otherwise could not be achieved using larger-sized particles.
Technological Advances are Helping Diagnose and Treat Early Stage Melanomas
According to estimates from the American Cancer Society, melanoma, the most serious form of skin cancer, was responsible for an estimated 8,650 deaths in the United States in 2009. Of growing concern among dermatologists is the fact that melanoma is now the most common form of cancer for young adults 25-29 years old and the second most common cancer in adolescents and young adults 15-29 years old.* Early diagnosis is the key to curing this potentially deadly disease, and diagnostic tools are playing a crucial role in aiding dermatologists to spot melanomas at earlier - and more curable - stages.
Dermatologists Address Parasitic Infestations Linked to Skin & Hair Problems
If simply the thought of bedbugs, scabies and head lice makes you feel a little itchy, imagine how those affected by these common infestations feel when they learn what has been creeping around them and causing symptoms such as intense itching, red bite marks or irritated scalps. Even less comforting is the fact that some parasitic infestations are on the rise, and can strike adults and children in unsuspecting places.
Skin of Color Population Faces Unique, but Treatable, Dermatologic Conditions
According to projections from the United States Census Bureau, people with skin of color will comprise approximately half of the U.S. population by 2050. This group, which includes African-Americans, Asians, Latinos and other ethnicities, are more prone to certain dermatologic problems than those with lighter skin tones due to their genetic make-up and in some cases cultural practices. For that reason, dermatologists - who understand the nuances of different skin tones - are poised to help patients of color by diagnosing and treating these conditions.
Research Reveals How Popular Skin Filler Works at the Molecular Level
In the U.S. and around the world, the popularity of minimally invasive cosmetic procedures continues to increase. Soft tissue injectables, also known as dermal fillers, are popular procedures that improve the appearance of aging and sun-damaged skin by restoring lost volume and filling lines. A recent clinical study sheds light on how cross-linked hyaluronic acid, CL-HA, a widely used dermal filler, works to improve skin appearance.
STELARA™ and REMICADE® Data to be Presented
Data evaluating the efficacy and safety of STELARA™ (ustekinumab) and REMICADE® (infliximab) in patients with plaque psoriasis who had an inadequate response to Enbrel® (etanercept) will be presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) in Miami, Fla., from March 5-9, 2010. Cumulative safety data for STELARA™ (up to 18 months) based on pooled analyses of one Phase 2 and two Phase 3 clinical trials will also be presented.
American Academy of Dermatology Holds 68th Annual Meeting
The American Academy of Dermatology (Academy) will hold its 2010 Annual Meeting in Miami Beach at the Miami Beach Convention Center. With an anticipated attendance of more than 17,000, this meeting will feature world-renowned leaders in the field of dermatology and presentations on the latest research in the diagnosis and medical, surgical and cosmetic treatment of skin, hair and nail conditions.
AADA Disappointed in Congress
The American Academy of Dermatology Association (AADA) is disappointed that the United States Congress has failed to approve legislation preventing the implementation of a 21 percent cut in payments for physicians who treat Medicare patients.
Lerner Medical Devices Launches New Levia Website
Lerner Medical Devices, Inc. today launched its medical device product website mylevia.com. Levia® provides Personal Targeted Phototherapy™ for the self-treatment of small area and scalp psoriasis. This new, safe and effective treatment is directed by a physician and guided by the patient with Levia's touch-screen user interface. Levia enables patients to privately and personally treat themselves with therapeutic ultraviolet B (UVB) light at home.
Study Showed Sculptra® Aesthetic Effectively Corrects Nasolabial Folds
Results published in today's online issue of the Journal of American Academy of Dermatology showed that treatment with Sculptra®Aesthetic (injectable poly-L-lactic acid) was significantly more effective than a human-derived collagen treatment CosmoPlast®* in correcting shallow to deep nasolabial fold (NLF) wrinkles (smile lines). In addition, this study demonstrated that the effect in correcting the NLF wrinkles with SculptraAesthetic can last for up to 25 months.